[Remote] Senior/ Staff Research Engineer at Abata Therapeutics

London, England, United Kingdom

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, Artificial Intelligence, Drug DiscoveryIndustries

Skills

Key technologies and capabilities for this role

AIMachine LearningDeep LearningGenerative AIDrug DiscoveryDistributed TrainingGPUModel OptimizationTechnical DocumentationResearch

Questions & Answers

Common questions about this position

What is the salary range for this Senior/Staff Research Engineer position?

This information is not specified in the job description.

Is this role remote or does it require working from an office?

This information is not specified in the job description.

What skills and experience are required for this AI Research Engineer role?

Candidates need 7+ years of industry experience in AI/ML, proficiency in Python and C++ with deep expertise in PyTorch/Jax, strong deep learning fundamentals, experience in distributed training on thousands of GPUs using DDP/FSDP, and performance optimization of large-scale AI models.

What is the company culture like at Xaira Therapeutics?

The role involves working as a senior member of an interdisciplinary group in a fast-paced, multidisciplinary team environment, collaborating closely with AI scientists, engineers, and drug discovery experts.

What makes a strong candidate for this position?

A strong candidate has a Bachelor's degree in Computer Science or related field, 7+ years of AI/ML industry experience with production deployments, expertise in Python/C++/PyTorch/Jax, large-scale distributed training on GPUs, model optimization, and excellent communication skills for multidisciplinary teams.

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters

2021Year Founded

$184.8MTotal Funding

EARLY_VCCompany Stage

BiotechnologyIndustries

11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.

Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.

Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.

Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.

Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.

FDA's accelerated approval pathways may expedite Abata's clinical trials.

Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI

Try Jobo Free